Technically, the market is now in an intermediate-term downtrend, which tells us that additional defensive measures would be prudent. In the very short term, however, I expect a bounce from today’s high-profile decline, so I’m mainly holding.
Read More
On Friday, the September 78 call that we sold expired worthless.
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Benjamin Graham was the father of value investing, and these were his seven primary criteria for selecting winning value stocks.
Read More
Tyler Laundon discusses the market's ongoing consolidation and advises investors to remain patient. He also serves up ten growth stocks that look compelling, for different reasons, right now.
Read More
The major indexes have bounced a bit this week, though compared to the prior two declines, it’s not much to brag about—as of this morning, the big-cap indexes are up a bit less than 1%, though the broader indexes (small- and mid-caps) are around...
Read More
From Cabot Top Ten Trader
The major indexes have bounced a bit this week, though compared to the prior two declines, it’s not much to brag about—as of this morning, the big-cap indexes are up a bit less than 1%, though the broader indexes and...
Read More
Thanks to China's rapid recovery from Covid-19, chemical stocks are on the rise. Here are three benefitting the most.
Read More
The market and big-winning growth stocks from this year remain iffy—today’s drop put our Cabot Tides on the fence and many growth stocks are still in a rough patch.
Read More
The flavor of the market hasn’t changed in the last week, in my view. There is still a sense that many high growth stocks have run too far. I think the lesser-informed general public hears about the recent slide in the mega-caps (AAPL, MSFT,...
Read More
The trend favoring highly scalable, high growth U.S. technology stocks is unlikely to change in the near future but diversifying into different countries and sectors is a good idea as we move into the fourth quarter.
Read More
Tomorrow is the expiration of five of our September covered call trades. It was another great month for the Cabot Profit Booster portfolio!
Read More
The markets have been a bit choppy of late, with the Dow Jones Industrial Average rising to 29,000 at the beginning of the month, then retreating and rising again. It looks like Fall may be a little volatile. As you’ll see in our Advisor Barometer...
Read More
Worried about how to invest before a presidential election? For starters, don't let emotions (or your politics) cloud your decision-making.
Read More
After a sharp two-week correction, some positive stock market trends have emerged. Here are 3 that I see - plus 3 stocks leading the rebound.
Read More
There hasn’t been any real news about our stocks in the past week, but I’ve been watching the charts carefully, trying to decide whether it’s time to put some of our 35% cash back into the market, or to take more out, or simply...
Read More
It may seem unnecessary to write covered calls in a raging bull market. but that’s seldom the case. Over time you are likely to get a better return with this income strategy than just holding a market index. And you get a paycheck.
Read More
The raging bull market took a breather. The S&P 500 actually pulled back 7% from the high at the peak of the recent Labor Day selloff. But that seems to be over. The market has since regained some traction and appears to be an...
Read More
Stock Name
Market Cap
Price
Investment Type
Kinsale Capital (KNSL)
$4.2 billion
191.94
Rapid Growth – P&C Insurance
Nevro (NVRO)
$4.9 billion
144.55
Rapid Growth – MedTech
Peloton (PTON)
$24.7 billion
85.45
Rapid Growth – Exercise Equipment
Varonis (VRNS)
$3.6 billion
112.46
Rapid Growth – Software
Vital Farms (VITL)
$1.5 billion
36.65
Rapid Growth – Eggs & Butter
Time Is on Our Side
In 1964 the Rolling Stones their...
Read More
